First AD

Second AD

Mikkael A. Sekeres, MD, is a professor of medicine and chief of the Division of Hematology, in the Leukemia Section, at the Sylvester Comprehensive Cancer Center, University of Miami Health System.

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Management of Myelodysplastic Syndromes in High-Risk Patients

OncLive Insights

Yazan Madanat, M.D and Mikkael A. Sekeres, M.D. discuss considerations in the classification of myelodysplastic syndrome taking into account disease heterogeneity.

Classification of Myelodysplastic Syndrome

Clinical Considerations in the Diagnosis of MDS

MDS: Risk Assessment Tools

High-Risk MDS: Prognostic and Predictive Factors

Clinical Implications of High-Risk MDS

High-Risk MDS: Clinical Efficacy Data

MDS Treatment-Related Toxicity and AEs

MDS Treatment: Patient Considerations

MDS: Clinical Primary Endpoints

Unmet Needs in MDS

MDS Treatment Selection: Impact of QoL

Future Directions in MDS